Literature DB >> 23868500

Immune system: a double-edged sword in cancer.

Bodduluru Lakshmi Narendra1, Kasala Eshvendar Reddy, Saladi Shantikumar, Sistla Ramakrishna.   

Abstract

OBJECTIVE: The objective of the review is to examine the role of innate and adaptive immune cells in cancer.
INTRODUCTION: Immune system functions as a host defensive mechanism protecting against invading pathogens and transformed cells, including cancer. However, a body of research carried out over the last few decades has disclosed the unexpected role of immune system in fostering the tumor growth.
METHODS: A computer-based online search was performed in the PubMed, Scopus and Web of Science databases for articles published, concerning natural killer (NK) cells, Macrophages, CD4+ and CD8+ T cells with relevance to cancer. After finding relevant articles within these search limits, a manual search was conducted through the references from these articles. RESULTS AND
CONCLUSIONS: This review summarizes the role of immune system in Immunosurveillance and Immunoediting. It then focused mainly on role of macrophages, regulatory T cells (Treg), TH17 cells and on the immunosuppressive mechanisms, which facilitate immune evasion of tumor cells. Our results shows that, immune cells, such as CD8+ cytotoxic T lymphocytes (CTL), CD4+ T helper (TH)1 cells and NK cells along with their characteristic cytokine interferon (IFN)-γ, function as major antitumor effector cells. Whereas CD4+TH2 cells, myeloid-derived suppressor cells (MDSCs) and their derived cytokines function as dominant tumor-promoting forces. In contrast to these cells, macrophages, Treg, and TH17 cells show a dual effect in cancer. Thus, it appears that most components of the immune system are potentially endowed with dual functions i.e., promoting tumor development on the one hand and restraining tumor development on the other and hence immune system can be considered as a double-edged sword in cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23868500     DOI: 10.1007/s00011-013-0645-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  89 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers.

Authors:  M S Shin; H S Kim; S H Lee; W S Park; S Y Kim; J Y Park; J H Lee; S K Lee; S N Lee; S S Jung; J Y Han; H Kim; J Y Lee; N J Yoo
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 3.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 4.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

5.  Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling.

Authors:  Wei Tan; Weizhou Zhang; Amy Strasner; Sergei Grivennikov; Jin Q Cheng; Robert M Hoffman; Michael Karin
Journal:  Nature       Date:  2011-02-16       Impact factor: 49.962

Review 6.  Role of TGF-beta in immune-evasion of cancer.

Authors:  C Beck; H Schreiber; D Rowley
Journal:  Microsc Res Tech       Date:  2001-02-15       Impact factor: 2.769

7.  Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.

Authors:  Rebecca P Petersen; Michael J Campa; Justin Sperlazza; Debbi Conlon; Mary-Beth Joshi; David H Harpole; Edward F Patz
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

8.  Augmentation of metastasis formation by thioglycollate-elicited macrophages.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; H T Holden; R B Herberman
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

9.  Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.

Authors:  Xuefang Cao; Sheng F Cai; Todd A Fehniger; Jiling Song; Lynne I Collins; David R Piwnica-Worms; Timothy J Ley
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

Review 10.  Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Authors:  Fabian Benencia; Leslee Sprague; John McGinty; Michelle Pate; Maria Muccioli
Journal:  J Biomed Biotechnol       Date:  2012-03-15
View more
  55 in total

1.  Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.

Authors:  Daniel Delitto; Chelsey Perez; Song Han; David H Gonzalo; Kien Pham; Andrea E Knowlton; Christina L Graves; Kevin E Behrns; Lyle L Moldawer; Ryan M Thomas; Chen Liu; Thomas J George; Jose G Trevino; Shannon M Wallet; Steven J Hughes
Journal:  Cancer Immunol Immunother       Date:  2015-09-30       Impact factor: 6.968

Review 2.  Towards tumor immunodiagnostics.

Authors:  Helen Kourea; Vassiliki Kotoula
Journal:  Ann Transl Med       Date:  2016-07

Review 3.  Inflammation and prostate cancer: friends or foe?

Authors:  Gianluigi Taverna; Elisa Pedretti; Giuseppe Di Caro; Elena Monica Borroni; Federica Marchesi; Fabio Grizzi
Journal:  Inflamm Res       Date:  2015-03-19       Impact factor: 4.575

4.  Anti-neoplastic and immunomodulatory potency of co-treatment based on bovine lactoferrin and/or muramyl dipeptide in tumor-bearing mice.

Authors:  Hany M Ibrahim; Azza H Mohamed; Mohamed L Salem; Gamalat Y Osman; Dalia S Morsi
Journal:  Toxicol Res (Camb)       Date:  2020-04-24       Impact factor: 3.524

5.  Heparanase is required for activation and function of macrophages.

Authors:  Lilach Gutter-Kapon; Dror Alishekevitz; Yuval Shaked; Jin-Ping Li; Ami Aronheim; Neta Ilan; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-14       Impact factor: 11.205

Review 6.  Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?

Authors:  G O'Callaghan; A Houston
Journal:  Br J Pharmacol       Date:  2015-10-26       Impact factor: 8.739

Review 7.  Formation and role of exosomes in cancer.

Authors:  Lindsey T Brinton; Hillary S Sloane; Mark Kester; Kimberly A Kelly
Journal:  Cell Mol Life Sci       Date:  2014-10-22       Impact factor: 9.261

8.  Galectin-3 Binding Protein Secreted by Breast Cancer Cells Inhibits Monocyte-Derived Fibrocyte Differentiation.

Authors:  Michael J V White; David Roife; Richard H Gomer
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

9.  14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma.

Authors:  Xinguang Han; Yongfu Han; Huifeng Jiao; Yaqiong Jie
Journal:  Mol Cells       Date:  2014-12-30       Impact factor: 5.034

10.  Comprehensive Analysis of the Neutrophil-to-Lymphocyte Ratio for Preoperative Prognostic Prediction Nomogram in Gastric Cancer.

Authors:  Jong-Ho Choi; Yun-Suhk Suh; Yunhee Choi; Jiyeon Han; Tae Han Kim; Shin-Hoo Park; Seong-Ho Kong; Hyuk-Joon Lee; Han-Kwang Yang
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.